Basel Medical Group Ltd (BMGL)
NASDAQ: BMGL · Real-Time Price · USD
4.450
+0.020 (0.45%)
At close: Oct 22, 2026, 4:00 PM EDT
4.460
+0.010 (0.22%)
After-hours: Oct 22, 2026, 7:30 PM EDT
Basel Medical Group Revenue
Basel Medical Group had revenue of 8.42M SGD in the half year ending December 31, 2025, with 65.44% growth. This brings the company's total for the last twelve months to 14.74M, up 47.35% year-over-year. In the fiscal year ending June 30, 2025, Basel Medical Group had annual revenue of 11.35M with 12.97% growth. That makes Basel Medical Group the 36,708th largest company in the world by revenue and 4,820th in the United States.
Revenue (ttm)
14.74M SGD
Revenue Growth
+47.35%
P/S Ratio
0.62
Revenue / Employee
179,708 SGD
Employees
82
Market Cap
7.04M USD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 11.35M | 1.30M | 12.97% |
| Jun 30, 2024 | 10.05M | 304.04K | 3.12% |
| Jun 30, 2023 | 9.75M | -911.62K | -8.55% |
| Jun 30, 2022 | 10.66M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
BMGL News
- 14 days ago - Basel Medical prices $7.98M registered direct offering - TheFly
- 14 days ago - Basel Medical Group Ltd (BMGL) Prices Registered Direct Offering - GlobeNewsWire
- 5 weeks ago - Basel Medical files to sell 6M units - TheFly
- 5 weeks ago - Basel Medical Group Ltd trading resumes - TheFly
- 5 weeks ago - Basel Medical Group Ltd trading halted, volatility trading pause - TheFly
- 5 weeks ago - Basel Medical Group Ltd trading resumes - TheFly
- 5 weeks ago - Basel Medical Group Ltd trading halted, volatility trading pause - TheFly
- 3 months ago - BMGL Regains Compliance With Nasdaq Minimum Bid Price Requirement - GlobeNewsWire